tiprankstipranks
Theratechnologies sees 2023 revenue $90M-$95M, consensus $95.44M
The Fly

Theratechnologies sees 2023 revenue $90M-$95M, consensus $95.44M

CEO Paul Levesque said, "Having confidently developed the right strategy for commercial success, we have set full fiscal year 2023 revenue guidance to be in the range of $90 million and $95 million, representing growth of between 13% and 19% as compared to 2022. More encouragingly, in our commitment to hold fast to fiscal responsibility and also based on the strength of our commercial portfolio, we expect to end 2023 on a strong path to positive cash flow from operations, setting the stage for even more leverage in years to come. The commercial infrastructure we have built in the United States will also serve as a platform to grow both our current products, as well as potential new accretive product acquisitions or in-licensing of commercial assets."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on THTX:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles